Complete remission in a patient with acute myelogenous leukemia treated with erlotinib for non small-cell lung cancer.

Aged Carcinoma, Small Cell/pathology,therapy Combined Modality Therapy Erlotinib Hydrochloride Humans Leukemia, Myeloid, Acute/pathology,therapy Lung Neoplasms/pathology,therapy Male Neoplasms, Second Primary/pathology,therapy Protein Kinase Inhibitors/administration & dosage Quinazolines/administration & dosage Remission Induction

Protein Kinase Inhibitors Quinazolines Erlotinib Hydrochloride